Segui
Douglas Osei-Hyiaman
Titolo
Citata da
Citata da
Anno
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman, M DePetrillo, P Pacher, J Liu, S Radaeva, S Bátkai, ...
The Journal of clinical investigation 115 (5), 1298-1305, 2005
13312005
A biosynthetic pathway for anandamide
J Liu, L Wang, J Harvey-White, D Osei-Hyiaman, R Razdan, Q Gong, ...
Proceedings of the National Academy of Sciences 103 (36), 13345-13350, 2006
5452006
Evidence for novel cannabinoid receptors
M Begg, P Pacher, S Bátkai, D Osei-Hyiaman, L Offertáler, FM Mo, J Liu, ...
Pharmacology & therapeutics 106 (2), 133-145, 2005
5312005
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
J Tam, VK Vemuri, J Liu, S Bátkai, B Mukhopadhyay, G Godlewski, ...
The Journal of clinical investigation 120 (8), 2953-2966, 2010
5222010
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
D Osei-Hyiaman, J Liu, L Zhou, G Godlewski, J Harvey-White, W Jeong, ...
The Journal of clinical investigation 118 (9), 3160-3169, 2008
5042008
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
S Bátkai, P Pacher, D Osei-Hyiaman, S Radaeva, J Liu, J Harvey-White, ...
Circulation 110 (14), 1996-2002, 2004
3722004
Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver
W Jeong, D Osei-Hyiaman, O Park, J Liu, S Bátkai, P Mukhopadhyay, ...
Cell metabolism 7 (3), 227-235, 2008
3502008
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
S Bátkai, D Osei-Hyiaman, H Pan, O El-Assal, M Rajesh, ...
The FASEB journal: official publication of the Federation of American …, 2007
3122007
Dietary linoleic acid elevates endogenous 2‐AG and anandamide and induces obesity
AR Alvheim, MK Malde, D Osei‐Hyiaman, YH Hong, RJ Pawlosky, ...
Obesity 20 (10), 1984-1994, 2012
2722012
Cell type–dependent pro-and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury
N Horiguchi, L Wang, P Mukhopadhyay, O Park, WI Jeong, F Lafdil, ...
Gastroenterology 134 (4), 1148-1158, 2008
1942008
Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?
G Kunos, D Osei-Hyiaman, S Bátkai, KA Sharkey, A Makriyannis
Trends in pharmacological sciences 30 (1), 1-7, 2009
1822009
Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis
M Rajesh, H Pan, P Mukhopadhyay, S Batkai, D Osei-Hyiaman, G Haskó, ...
Journal of Leucocyte Biology 82 (6), 1382-1389, 2007
1692007
PPAR/RXR regulation of fatty acid metabolism and fatty acid ω-hydroxylase (CYP4) isozymes: implications for prevention of lipotoxicity in fatty liver disease
JP Hardwick, D Osei-Hyiaman, H Wiland, MA Abdelmegeed, BJ Song
PPAR research 2009, 2009
1562009
Endocannabinoids and the control of energy homeostasis
G Kunos, D Osei-Hyiaman, J Liu, G Godlewski, S Batkai
Journal of biological chemistry 283 (48), 33021-33025, 2008
1442008
Cocaine-and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide
D Osei-Hyiaman, M Depetrillo, J Harvey-White, AW Bannon, BF Cravatt, ...
Neuroendocrinology 81 (4), 273-282, 2005
1362005
Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patients
L Hou, D Osei-Hyiaman, H Yu, Z Ren, Z Zhang, B Wang, S Harada
Neurology 56 (4), 490-496, 2001
1182001
Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-γ
B Mukhopadhyay, J Liu, D Osei-Hyiaman, G Godlewski, P Mukhopadhyay, ...
Journal of biological chemistry 285 (25), 19002-19011, 2010
1122010
The role of the endocannabinoid system in the control of energy homeostasis
D Osei-Hyiaman, J Harvey-White, S Batkai, G Kunos
International journal of obesity 30 (1), S33-S38, 2006
1082006
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects
G Godlewski, SO Alapafuja, S Bátkai, SP Nikas, R Cinar, L Offertáler, ...
Chemistry & biology 17 (11), 1256-1266, 2010
982010
Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase
P Pacher, S Bátkai, D Osei-Hyiaman, L Offertáler, J Liu, J Harvey-White, ...
American Journal of Physiology-Heart and Circulatory Physiology 289 (2 …, 2005
912005
Il sistema al momento non puň eseguire l'operazione. Riprova piů tardi.
Articoli 1–20